Oncology Practice and COVID-19: Addressing the Challenges With Mark A. Lewis, MD

The COVID-19 pandemic has created multiple challenges to cancer care, ranging from the risk of exposure to novel coronavirus involved in having patients come to the hospital or clinic for treatment to the risks that immunosuppressive cancer treatments––and cancer itself––may pose in making patients more susceptible to COVID-19. How should these risks be balanced against the necessity of life-preserving cancer therapies? Mark A. Lewis, MD, Director of Gastrointestinal Oncology at Intermountain He...
Continue reading

Cancer Research and the Art of Spin

At oncology meetings, nearly one third of oral presentations on cancer clinical trials where the primary end point was not met presented a positive, or "not negative," conclusion about a formally negative result, according to results of a quality improvement analysis now published in JAMA Oncology."Presentations at medical meetings have great resonance within the scientific community, especially following the diffusion of social media," write the investigators, led by first author Massimo Di Mai...
Continue reading

Closing the Gender Gap in Oncology Academic Leadership: Reshma Jagsi, MD, DPhil

​A recent study by Mudit Chowdhary, MD, and colleagues revealed that a substantial gender gap remains in academic oncology leadership: in a web query of 265 of the 273 accredited medical, radiation, and surgical oncology training programs, only 35.9% of faculty members were women. Representation was substantially lower among department chairs, with 21.7% of medical oncology programs, 11.7% of radiation oncology programs, and a mere 3.8% of surgical oncology programs chaired by women. In this int...
Continue reading

CAR T-Cell Therapy: Oncology Nurses’ Educational Needs

Pre-activity assessment data from i3 Health's nursing continuing professional development (NCPD) activity "Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies" has revealed significant baseline knowledge gaps regarding the use of chimeric antigen receptor (CAR) T-cell therapy for the treatment of patients with B-cell malignancies.Of the 584 learners who took the pretest and began the activity, 539 saw it through to completion. The learners who completed the acti...
Continue reading

Women Underrepresented in Academic Oncology Program Leadership

​Results of a cross-sectional study of accredited US medical oncology, radiation oncology, and surgical oncology training programs reveal that women are markedly underrepresented in academic leadership positions across the oncology disciplines."As women constitute half of the US population, and cancer is the second leading cause of death for men and women, promoting a more gender-balanced workforce more representative of its patient population is critical," write the investigators of the study p...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.